Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial

Overview of attention for article published in British Journal of Cancer, March 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 42 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 5,293 followers.

"Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial" https://t.co/zr7EOicYqB

19 Mar 2018

Reply Repost Favourite